Zanamivir
SIGMA/SML0492 - ≥98% (HPLC)
Synonym: 4-
CAS Number: 139110-80-8
Empirical Formula (Hill Notation): C12H20N4O7
Molecular Weight: 332.31
MDL Number: MFCD00866966
Linear Formula: C12H20N4O7
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C12H20N4O7/c1-4(18)15- |
| InChI key | ARAIBEBZBOPLMB-UFGQHTETSA |
| optical activity | [α]/D +30 to +40°, c = 1 in H2O |
| Quality Level | 100 ![]() |
| SMILES string | CC(=O)N[C@@H]1[C@@H](NC(N |
| solubility | H2O: 10 mg/mL, clear |
| storage temp. | room temp |
| Application: | Zanamivir has been used: • as a neuraminidase inhibitor to study its effects on influenza A virus (IAV) like particles • as a neuraminidase inhibitor to study its effects on lipopolysaccharide (LPS)-mediated pathology in sepsis • as an antiviral to study its effects on influenza B virus by plaque reduction assay |
| Biochem/physiol Actions: | Zanamivir exhibits therapeutic effects against influenza caused by influenza virus A and B. |
| Biochem/physiol Actions: | Zanamivir is an influenza viral neuraminidase inhibitor. |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H315 - H319 - H335 |
| Precautionary statements | P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xn |
| Risk Statements | 22-36/37/38 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |


